1. Home
  2. GHG vs SGHT Comparison

GHG vs SGHT Comparison

Compare GHG & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GHG

GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share

HOLD

Current Price

$1.20

Market Cap

171.6M

ML Signal

HOLD

Logo Sight Sciences Inc.

SGHT

Sight Sciences Inc.

HOLD

Current Price

$3.80

Market Cap

187.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GHG
SGHT
Founded
2004
2011
Country
China
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
171.6M
187.4M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
GHG
SGHT
Price
$1.20
$3.80
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$9.08
AVG Volume (30 Days)
21.3K
389.5K
Earning Date
04-23-2026
03-04-2026
Dividend Yield
4.25%
N/A
EPS Growth
N/A
28.16
EPS
N/A
N/A
Revenue
N/A
$77,363,000.00
Revenue This Year
$19.02
$11.81
Revenue Next Year
$8.26
$10.62
P/E Ratio
$5.76
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.14
$2.03
52 Week High
$2.78
$9.24

Technical Indicators

Market Signals
Indicator
GHG
SGHT
Relative Strength Index (RSI) 38.64 40.10
Support Level $1.17 $3.29
Resistance Level $1.35 $4.34
Average True Range (ATR) 0.07 0.21
MACD 0.00 0.09
Stochastic Oscillator 36.36 54.29

Price Performance

Historical Comparison
GHG
SGHT

About GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share

GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The hotel network of the company comprised approximately 4,059 hotels with nearly 302,497 rooms in China, covering all centrally administrated municipalities and cities throughout all provinces and autonomous regions in China. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The company operates solely in China and generates all its revenue from China itself.

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.

Share on Social Networks: